GlassScriptPhysician profile
Steven D Lin
NPI 1699901397
$4,408.78
in general payments reported to CMS, 2019-2025
10 companies · $1,362 in 2025
The $1,362 reported for 2025 was more than what 78% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.22 · 2020: $44.68 · 2021: $39.30 · 2022: $2,895 · 2023: $19.64 · 2024: $23.42 · 2025: $1,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $729 · Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $728.64 |
| Food and Beverage | $676.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,856.41 | 2022 | |
| Sonex Health, INC. | $1,343.34 | 2025 | Sx-One Microknife |
| Endo Pharmaceuticals INC. | $58.94 | 2021-2023 | Xiaflex |
| Baxter Healthcare | $38.93 | 2022 | |
| Integra Lifesciences Corporation | $24.42 | 2020 | |
| Axogen | $24.22 | 2019 | |
| Endo USA, INC. | $23.42 | 2024 | Xiaflex |
| Allergan, INC. | $20.26 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $18.84 | 2025 | Caldolor |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$78,198.69 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.